- Clinical Technology
- Adult Immunization
- Hepatology
- Pediatric Immunization
- Screening
- Psychiatry
- Allergy
- Women's Health
- Cardiology
- Pediatrics
- Dermatology
- Endocrinology
- Pain Management
- Gastroenterology
- Infectious Disease
- Obesity Medicine
- Rheumatology
- Nephrology
- Neurology
- Pulmonology
Asthma of Obesity: Investigator Explains the Phenotypes
Asthma of obesity affects more than 10% of men and 14% of women with obesity. Our interview with researcher Anne Dixon, MD, sheds light on this poorly appreciated asthma phenotype.
The connection between asthma and obesity is a complex one, according to pulmonologist and critical care medicine specialist Anne Dixon, MD. It is also not fully understood, even among asthma specialists.
Asthma of obesity affects approximately 1 in 10 men with obesity (11%) and nearly 14% of women with obesity and for a variety of reasons presents a significant treatment challenge.
Anne Dixon, MD, is a leading researcher in the complex area of asthma phenotypes and obesity and metabolism. She is professor of medicine at the Robert Larner School of Medicine at the University of Vermont, director of Pulmonary and Critical Care Medicine and director of the Vermont Lung Center. Patient Care recently asked her to talk about these overlapping diseases and particularly as they affect the primary care practitioner.
Anne Dixon, MD, is Professor of Medicine, Director, Pulmonary and Critical Care Medicine, Robert Larner School of Medicine, University of Vermont, Director, Vermont Lung Center
Lilly’s Oral GLP-1 Orforglipron Meets End Points in Phase 3 Obesity and Diabetes Trial
August 26th 2025Patients taking orforglipron achieved significant weight loss, hemoglobin A1c reduction, and cardiometabolic benefits in the phase 3 ATTAIN-2 study, supporting upcoming global regulatory submissions.
